Skip to main content
Caplight Logo









Laplace Interventional

Laplace Interventional

Private
Plymouth, MinnesotaHealthcare & Life Scienceshttps://laplaceint.com/

Last Round

Series C

Mar 16, 2025

Total Funding Raised

$42.8M

Company Overview

Laplace Interventional is a medical device company developing a minimally invasive transcatheter tricuspid valve replacement system to treat tricuspid regurgitation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

transcatheter tricuspid valve replacementTTVRstructural hearttricuspid regurgitationminimally invasive surgerypercutaneous valveinterventional cardiologyprosthetic heart valvecatheter delivery systemtrans-jugular deliverytrans-femoral deliverymedtechmedical deviceheart valve replacementearly feasibility study

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Laplace Interventional Comparables

Compare Laplace Interventional with similar companies based on industry and business-model similarity.

Laplace Interventional comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
VDyne
93%
Versa Vascular, Inc.
92%
Trisol Medical
91%

Laplace Interventional Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMar 16, 2025
Series BJul 24, 2023
Series ASep 1, 2021

Key People

Founding team and executive leadership

Ramji Iyer

Founder and CEO

Founding Team

Laplace Interventional Investors

Notable investors and investment history

Laplace Interventional investors
InvestorRounds
Aphelion CapitalSeries C
Features CapitalSeries C, Series B
Unorthodox VenturesSeries C
Alpha JWC VenturesSeries B
J.W.C. Venture CapitalSeries C
Mayo Clinic VenturesSeries A
ShangBay CapitalSeries A, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 14, 2025

    Grew 20% QoQ, from 15 to 18 employees.

  • Jun 8, 2025

    Grew 21% QoQ from 14 to 17 employees.

Laplace Interventional Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Laplace Interventional Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Laplace Interventional's valuation, stock price, and market status.

Firmographic Details

HeadquartersPlymouth, Minnesota
Employee Range20
Year Founded2020
Last FundingMar 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?